Drugs Used For Coagulation Disorders Flashcards
What anticlotting drugs are classified as Anticoagulants?
Heparins
Direct Thrombin Inhibitors
Direct Factor Xa inhibitors
Warfarin
What anticlotting drugs are classified as thrombolytics?
t-PA Derivatives
Aminocaproic Acid
What anticlotting drugs are classified as antiplatelet drugs?
Asprin
Gp IIb/IIIa inhibitors
ADP inhibitors (clopidogrel)
PDE/adenosine uptake inhibitors
What drugs are COX inhibitors?
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• ASPRIN (irreversible)
• Ibuprofen (reversible)
MOA:
• Asprin inhibits COX-1 and prevents TXA2 from being formed
What drugs are ADP P2Y212 inhibitors?
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• CLOPIDOGREL (preferred agent)
• TICLOPIDINE
• Prasugrel
MOA:
• Block the effects of ADP by blocking its receptor (P2Y212)
What drugs are Phosphodiesterase inhibitors
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• Dipyridamole
MOA:
• Blocks hydrolysis of cyclic nucleotides like cAMP and cGMP
What drugs are GpIIb/IIIa inhibitors
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• ABCIXIMAB
• EFTIBATIDE
• Tirofiban
MOA:
• Blocks binding of fibrinogen to the GpIIb/IIIa receptor, thus preventing platelet AGGREGATION
What drugs are PAR-1 inhibitors
• Drug Sub-Class of Clotting Drug
•MOA
Antiplatelet Drugs
• Vorapaxar
MOA:
• Blocks TXA2 RECEPTOR (PAR-1)
What happens when GPIIb/IIIa binds to fibrinogen?
• What is the GPIIb/IIIa conformational change dependent on?
- Conformational Change to HIGH AFF. Depends on Ca2+
- GPIIb/IIIa binds Fibrinogen - sends signal to platelets
- Platelet then Binds harder in an IRREVERSIBLE manner
Who shouldn’t use platelet inhibiting drugs?
• Anyone at a high risk of bleeding or that may undergo elective surgery soon
***Make sure you give a sufficient amount of time when you discontinue the drug for its effects to dissipate
Asprin***
• Why is it so specific for platelets?
• Is increased dosing ever necessary?
Asprin:
• Blocks COX-1 which is present in many cells and produces PGI2 (a platelet inhibitor) and TXA2 (a platelet aggregant)
- At low doses ENDOTHELIAL cells which make mostly PGI2 can compensate and upreulate COX-1 activity
- Platelets have NO NUCLEUS so no upregulation of COX-1 can happen and TXA2 ceases to be produced
Increased Dose:
• NOT NECESSARY, it will start to inhibit COX2
Asprin***
• Organs typically affected by dose-related toxicity
• Weird Adverse Effects
Organs
• GI tract causing potential for Bleeding and Perforation
• Hepatic and Renal function affected in OD
Weird Effects:
• In some ppl. Asprin induces bronchospasm
Clopidogrel***
• MOA
FIRST LINE therapy in hearth attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Ticlopidine***
• MOA
SECOND LINE therapy in heart attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Dipyridamole
used in heart attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Between the 3 drugs (clopidogrel, Ticlopidinek and Prasugrel) which are pro-drugs?
• How are these drugs given?
• Which shows the greatest variability in metabolism?
Pro-Drugs:
• Clopidogrel**
• Prasugrel
Active Drug:
• Ticlopidinek**- still gets activated to an even more active form.
Administration:
Oral
Variability:
Clopidogrel shows the greastest variability because of CYP2C19 polymorphisms
**Of the P2Y212 inhibitors, which has the most side effects?
• What are these effects?
• Name all of the inhibitors
Ticlopidinek** - SEVERE HEMATOLOGIC SIDE EFFECTS
• Agraulocytosis, Neutropenia
• **THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
• Anemia, Thrombocytopenia
All: Clopdigrel, Ticlopidinek, Prasugrel
Dipyridamole
• Use
• MOA
• Adverse Effects
Use:
• Prevention of Thrombosis in ppl. with prosthetic heart valves
MOA:
• Blocks Phosphodiesterase and causes elevated cAMP which has 2 effects
1. High cAMP prevents Arachiodonic Acid release
2. High cAMP prevents changes in platelet conformation
Adverse Effects:
• Not Remarkable
Abciximab***
MOA
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**Abciximab is a MONOCLONAL Ab. and binds the to Arg-Gly-Asp sequence
Eftibatide***
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**Derived from snake venom and binds Lys-Gly-Asp but is NOT an Ab.
Tirofiban
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**IS NOT an Ab. but binds the to Arg-Gly-Asp sequence
Explain the descrepancy in duration of action between the 3 drugs that bind GPIIa/IIIb.
• Name all of the drugs
Abciximab** is a MONOCLONAL Ab. so its action last for WEEKS (2 wks)
• Effects of Eptifibatide** and Tirofiban cease after only 4 hrs